Quality of life in Dukes' B and C colorectal carcinoma

  • Authors:
    • J Norum
    • B Vonen
    • A Revhaug
  • View Affiliations

  • Published online on: May 1, 1997     https://doi.org/10.3892/or.4.3.645
  • Pages: 645-648
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Adjuvant chemotherapy (ACT) is standard therapy in Dukes' C colorectal carcinoma (CRC) in several countries. Several studies have documented a significant improvement in overall survival, but the clinical efficacy on quality of life (QoL) has been doubted. To clarify this item, we performed a study on QoL in 94 CRC patients diagnosed between 1993-96 and randomised to surgery with or without ACT. 82 'survivors' were mailed the EORTC QLQ C-30. Sixty-two patients (76%) responded. They reported a high level of functioning and a low frequency of symptoms. ACT did not improve global QoL, and tended to cause less pain (p=0.023) and more nausea/vomiting (p=0.065).

Related Articles

Journal Cover

May 1997
Volume 4 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Norum J, Vonen B and Revhaug A: Quality of life in Dukes' B and C colorectal carcinoma. Oncol Rep 4: 645-648, 1997.
APA
Norum, J., Vonen, B., & Revhaug, A. (1997). Quality of life in Dukes' B and C colorectal carcinoma. Oncology Reports, 4, 645-648. https://doi.org/10.3892/or.4.3.645
MLA
Norum, J., Vonen, B., Revhaug, A."Quality of life in Dukes' B and C colorectal carcinoma". Oncology Reports 4.3 (1997): 645-648.
Chicago
Norum, J., Vonen, B., Revhaug, A."Quality of life in Dukes' B and C colorectal carcinoma". Oncology Reports 4, no. 3 (1997): 645-648. https://doi.org/10.3892/or.4.3.645